Katrina Thornber, Author at European Medical Journal - Page 34 of 35

Who is More at Risk of Adverse Events After Coronary Procedures?

New study highlights the need for targeted anti-inflammatory treatments to reduce adverse cardiovascular events in high-risk patients.

Pre-eclampsia Linked to Congenital Heart Disease in Newborns

A significant association has been established between pre-eclampsia and congenital heart disease in offspring.

Novel Blood Biomarkers for Mortality Risk in General Population

Recent research has revealed that the red blood cell distribution width to albumin concentration ratio is associated with increased all-cause and cause-specific mortality.

Long-Term Risks of β-lactam Allergies

An increased risk of antibiotic-resistant infections, for up to 12 years, is associated with β-lactam allergies, according to recent research.

Sodium Intake Associated with Atopic Dermatitis

Reduced intake of dietary sodium may be a cost-effective and low-risk treatment for atopic dermatitis (AD), according to recent research.

Vitamin C Associated with Improved Survival in Low-Risk Myeloid Malignancies

Results from a trial on the use of vitamin C supplementation for the treatment of low-risk myeloid malignancies were presented at the 2024 European Haematology Association Congress

Oral Contraceptive Pill Associated With Alopecia

A study shows oral contraceptive pill use affects the protective effect of the CYP1B1 variant against frontal fibrosing alopecia, increasing risk in females with OCP history.

Antibiotic Use in Infancy Linked to Atopic Dermatitis

Antibiotic use in early life has been associated with an increased risk of atopic dermatitis, likely due to gut microbiome disruption.

Novel Combination Therapy Shows Promising Results for Relapsed Multiple Myeloma

Belantamab combination therapy shows significant improvements in survival for relapsed/refractory multiple myeloma patients compared to pomalidomide plus bortezomib and dexamethasone

Fetal Origins of Paediatric Acute Myeloid Leukaemia

Researchers have uncovered crucial insights into the development of paediatric acute myeloid leukaemia, revealing that some cases may originate in the womb